Drawing on our extensive experience of seventeen years across emerging and developed markets worldwide, Strides entered the Indian domestic market in 2007 with a range of products for diabetes, cardiovascular diseases, neurology and female healthcare through the acquisition of Chennai based pharmaceutical company, Grandix Pharmaceuticals Limited.
Our domestic presence was further strengthened in 2009 with the introduction of a Critical Care products portfolio under a newly created division, Ray of Life. The Critical Care Business marks our entry into the high end Indian oncology, nephrology and antibiotics segment and offers the medical fraternity and consumers in India high quality healthcare products at an affordable price.
Our commitment to providing quality health care and our work ethic has attracted a skilled and energised workforce who are steering our growth in the domestic market. We continue to provide exciting career opportunities for young and talented healthcare professionals.